APO RESEARCH · REPORT
Heart Lung Machine
Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Product & engineering
Understand the product.
Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
Selected research
Market Outlook & Growth Opportunities
Global Heart Lung Machine Market Outlook and Growth Opportunities 2026
Market perspective
Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
North America is the largest sales place, with a sales market share nearly 36%. Following North America, Europe is the second largest sales place with the sales market share of 33%. China, Japan and Korea are also important sales regions for artificial heart lung machines.
Heart Lung Machine market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59% of revenue share. MAQUET followed as second produced about 18%.
Read the full market overview
This report provides an overview of the global Heart Lung Machine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Heart Lung Machine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Heart Lung Machine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Heart Lung Machine market size, projected growth trends, production technologies, key applications, and end-use industries.
Heart Lung Machine Segment by Company
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
Heart Lung Machine Segment by Type
Single Roller Pump Heart Lung Machine
Double Roller Pump Heart Lung Machine
Heart Lung Machine Segment by Application
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Other
Heart Lung Machine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Heart Lung Machine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Heart Lung Machine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Heart Lung Machine significant trends, drivers, influence factors in global and regions.
6. To analyze Heart Lung Machine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heart Lung Machine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heart Lung Machine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heart Lung Machine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Heart Lung Machine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Heart Lung Machine industry.
Chapter 3: Detailed analysis of Heart Lung Machine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Heart Lung Machine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Heart Lung Machine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Roller Pump Heart Lung Machine
- Double Roller Pump Heart Lung Machine
Applications
- Cardiac Surgery
- Lung Transplant Operation
- Acute Respiratory Failure Treatment
- Other
Companies covered
- LivaNova (Sorin)
- Getinge (Maquet)
- Medtronic
- Terumo CV Group
- Braile Biomedica
- Tianjin Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Heart Lung Machine Sales Value (2021-2032)
- 1.2.2 Global Heart Lung Machine Sales Volume (2021-2032)
- 1.2.3 Global Heart Lung Machine Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Heart Lung Machine Market Dynamics
- 2.1 Heart Lung Machine Industry Trends
- 2.2 Heart Lung Machine Industry Drivers
- 2.3 Heart Lung Machine Industry Opportunities and Challenges
- 2.4 Heart Lung Machine Industry Restraints
3 Heart Lung Machine Market by Company
- 3.1 Global Heart Lung Machine Company Revenue Ranking in 2025
- 3.2 Global Heart Lung Machine Revenue by Company (2021-2026)
- 3.3 Global Heart Lung Machine Sales Volume by Company (2021-2026)
- 3.4 Global Heart Lung Machine Average Price by Company (2021-2026)
- 3.5 Global Heart Lung Machine Company Ranking (2024-2026)
- 3.6 Global Heart Lung Machine Company Manufacturing Base and Headquarters
- 3.7 Global Heart Lung Machine Company Product Type and Application
- 3.8 Global Heart Lung Machine Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Heart Lung Machine Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Heart Lung Machine Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Heart Lung Machine Market by Type
- 4.1 Heart Lung Machine Type Introduction
- 4.1.1 Single Roller Pump Heart Lung Machine
- 4.1.2 Double Roller Pump Heart Lung Machine
- 4.2 Global Heart Lung Machine Sales Volume by Type
- 4.2.1 Global Heart Lung Machine Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Heart Lung Machine Sales Volume by Type (2021-2032)
- 4.2.3 Global Heart Lung Machine Sales Volume Share by Type (2021-2032)
- 4.3 Global Heart Lung Machine Sales Value by Type
- 4.3.1 Global Heart Lung Machine Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Heart Lung Machine Sales Value by Type (2021-2032)
- 4.3.3 Global Heart Lung Machine Sales Value Share by Type (2021-2032)
5 Heart Lung Machine Market by Application
- 5.1 Heart Lung Machine Application Introduction
- 5.1.1 Cardiac Surgery
- 5.1.2 Lung Transplant Operation
- 5.1.3 Acute Respiratory Failure Treatment
- 5.1.4 Other
- 5.2 Global Heart Lung Machine Sales Volume by Application
- 5.2.1 Global Heart Lung Machine Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Heart Lung Machine Sales Volume by Application (2021-2032)
- 5.2.3 Global Heart Lung Machine Sales Volume Share by Application (2021-2032)
- 5.3 Global Heart Lung Machine Sales Value by Application
- 5.3.1 Global Heart Lung Machine Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Heart Lung Machine Sales Value by Application (2021-2032)
- 5.3.3 Global Heart Lung Machine Sales Value Share by Application (2021-2032)
6 Heart Lung Machine Regional Sales and Value Analysis
- 6.1 Global Heart Lung Machine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Heart Lung Machine Sales by Region (2021-2032)
- 6.2.1 Global Heart Lung Machine Sales by Region: 2021-2026
- 6.2.2 Global Heart Lung Machine Sales by Region (2027-2032)
- 6.3 Global Heart Lung Machine Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Heart Lung Machine Sales Value by Region (2021-2032)
- 6.4.1 Global Heart Lung Machine Sales Value by Region: 2021-2026
- 6.4.2 Global Heart Lung Machine Sales Value by Region (2027-2032)
- 6.5 Global Heart Lung Machine Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Heart Lung Machine Sales Value (2021-2032)
- 6.6.2 North America Heart Lung Machine Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Heart Lung Machine Sales Value (2021-2032)
- 6.7.2 Europe Heart Lung Machine Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Heart Lung Machine Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Heart Lung Machine Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Heart Lung Machine Sales Value (2021-2032)
- 6.9.2 South America Heart Lung Machine Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Heart Lung Machine Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Heart Lung Machine Sales Value Share by Country, 2025 VS 2032
7 Heart Lung Machine Country-level Sales and Value Analysis
- 7.1 Global Heart Lung Machine Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Heart Lung Machine Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Heart Lung Machine Sales by Country (2021-2032)
- 7.3.1 Global Heart Lung Machine Sales by Country (2021-2026)
- 7.3.2 Global Heart Lung Machine Sales by Country (2027-2032)
- 7.4 Global Heart Lung Machine Sales Value by Country (2021-2032)
- 7.4.1 Global Heart Lung Machine Sales Value by Country (2021-2026)
- 7.4.2 Global Heart Lung Machine Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.9.2 France Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.16.2 China Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.19.2 India Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Heart Lung Machine Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Heart Lung Machine Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Heart Lung Machine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 LivaNova (Sorin)
- 8.1.1 LivaNova (Sorin) Company Information
- 8.1.2 LivaNova (Sorin) Business Overview
- 8.1.3 LivaNova (Sorin) Heart Lung Machine Sales, Value and Gross Margin (2021-2026)
- 8.1.4 LivaNova (Sorin) Heart Lung Machine Product Portfolio
- 8.1.5 LivaNova (Sorin) Recent Developments
- 8.2 Getinge (Maquet)
- 8.2.1 Getinge (Maquet) Company Information
- 8.2.2 Getinge (Maquet) Business Overview
- 8.2.3 Getinge (Maquet) Heart Lung Machine Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Getinge (Maquet) Heart Lung Machine Product Portfolio
- 8.2.5 Getinge (Maquet) Recent Developments
- 8.3 Medtronic
- 8.3.1 Medtronic Company Information
- 8.3.2 Medtronic Business Overview
- 8.3.3 Medtronic Heart Lung Machine Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Medtronic Heart Lung Machine Product Portfolio
- 8.3.5 Medtronic Recent Developments
- 8.4 Terumo CV Group
- 8.4.1 Terumo CV Group Company Information
- 8.4.2 Terumo CV Group Business Overview
- 8.4.3 Terumo CV Group Heart Lung Machine Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Terumo CV Group Heart Lung Machine Product Portfolio
- 8.4.5 Terumo CV Group Recent Developments
- 8.5 Braile Biomedica
- 8.5.1 Braile Biomedica Company Information
- 8.5.2 Braile Biomedica Business Overview
- 8.5.3 Braile Biomedica Heart Lung Machine Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Braile Biomedica Heart Lung Machine Product Portfolio
- 8.5.5 Braile Biomedica Recent Developments
- 8.6 Tianjin Medical
- 8.6.1 Tianjin Medical Company Information
- 8.6.2 Tianjin Medical Business Overview
- 8.6.3 Tianjin Medical Heart Lung Machine Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Tianjin Medical Heart Lung Machine Product Portfolio
- 8.6.5 Tianjin Medical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Heart Lung Machine Value Chain Analysis
- 9.1.1 Heart Lung Machine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Heart Lung Machine Sales Mode & Process
- 9.2 Heart Lung Machine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Heart Lung Machine Distributors
- 9.2.3 Heart Lung Machine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst